Bharat Biotech To Supply 3.5 Crore Covaxin Doses In September And 5 Crore In October; 10 Crore Monthly Supply Likely Only In 2022
Intranasal Covid Vaccines: How They Can Help Fight The Pandemic
Phase 1 Trials Of Bharat Biotech's Nasal Vaccine For Covid-19 Now Underway: MD Dr Krishna Ella
